Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention
- PMID: 23055013
- DOI: 10.1007/s12020-012-9808-7
Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention
Abstract
The aim of this study was to evaluate the effect of a six-month lifestyle intervention on ghrelin and asymmetrical dimethylarginine (ADMA) in obese Mexican adolescents. A total of 65 obese Mexican adolescents aged 10-16 years completed a six-month lifestyle intervention. Anthropometric and biochemical parameters were assessed at baseline and at six months. Twenty normal-weight adolescents were also evaluated at baseline. Insulin resistance (IR) was determined by the homeostasis model assessment of IR (HOMA-IR). Ghrelin and ADMA were determined by enzyme-linked immunosorbent assay. Obese adolescents presented significantly higher triglycerides, cholesterol, glucose, insulin, HOMA-IR, and ADMA levels, while ghrelin was significantly lower. The lifestyle intervention led to a significant improvement in HOMA-IR, ghrelin, and ADMA in the whole studied obese subjects. ADMA and ghrelin levels were associated with BMI and IR components. According to the value of HOMA-IR, the obese subjects were divided into subjects with or without IR, no difference in ghrelin and ADMA was observed in these two subgroups. After intervention, the obese with IR showed increased ghrelin and decreased ADMA, while the obese without IR only showed improvement in ghrelin. The multiple linear regression analysis revealed that the changes of systolic blood pressure were the only predictor for the changes of ghrelin in the obese with IR. Our study demonstrated the increase of ADMA and the decrease of ghrelin in obese adolescents. Lifestyle intervention improved insulin resistance, decreased ADMA, and increased ghrelin in obese subjects with IR although no significant weight loss was observed.
Similar articles
-
Metabolic syndrome, adipokines and ghrelin in overweight and obese schoolchildren: results of a 1-year lifestyle intervention programme.Eur J Pediatr. 2011 Apr;170(4):483-92. doi: 10.1007/s00431-010-1316-2. Epub 2010 Oct 19. Eur J Pediatr. 2011. PMID: 20957391 Clinical Trial.
-
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes.Exp Clin Endocrinol Diabetes. 2009 Nov;117(10):600-4. doi: 10.1055/s-0029-1225353. Epub 2009 Jul 17. Exp Clin Endocrinol Diabetes. 2009. PMID: 19618346
-
Blood pressure from childhood to adolescence in obese youths in relation to insulin resistance and asymmetric dimethylarginine.J Endocrinol Invest. 2016 Feb;39(2):169-76. doi: 10.1007/s40618-015-0351-2. Epub 2015 Jul 16. J Endocrinol Invest. 2016. PMID: 26178736
-
Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.Int J Obes (Lond). 2007 Jan;31(1):15-22. doi: 10.1038/sj.ijo.0803453. Epub 2006 Sep 5. Int J Obes (Lond). 2007. PMID: 16953257
-
Sleep efficiency as a determinant of insulin sensitivity in overweight and obese adolescents.Diabetes Obes Metab. 2015 Sep;17 Suppl 1:90-8. doi: 10.1111/dom.12515. Diabetes Obes Metab. 2015. PMID: 26332973 Review.
Cited by
-
Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin.J Med Biochem. 2020 Oct 2;39(4):452-459. doi: 10.5937/jomb0-24683. J Med Biochem. 2020. PMID: 33312061 Free PMC article.
-
Interventions to Treat Obesity in Mexican Children and Adolescents: Systematic Review and Meta-Analysis.Nutr Rev. 2022 Feb 10;80(3):544-560. doi: 10.1093/nutrit/nuab041. Nutr Rev. 2022. PMID: 34339511 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical